Search Within

Dmitriy Zamarin

Formats
  1. Journal Article (101)
  2. Meeting Abstract (85)
  3. Editorial (7)
  4. Guidelines (3)
  5. Review (3)
  6. Book Section (2)
Groups
  1. Department of Medicine (201)
  2. GDMT, Medicine (201)
  3. Gynecologic Medicine Service (201)
  4. Gynecology Disease Management Team (201)
  5. Solid Tumor Oncology Division (201)
  6. GSK Faculty (75)

More Groups

People
  1. Carol Aghajanian (60)
  2. Britta Weigelt (50)
  3. Roisin O'Cearbhaill (42)
  4. Claire Friedman (40)
  5. Jedd Wolchok (34)
  6. Nadeem Abu-Rustum (34)

More People

Years
  1. 2024 (8)
  2. 2023 (18)
  3. 2022 (40)
  4. 2021 (16)
  5. 2020 (43)
  6. 2019 (14)

More Years

Publications
  1. Gynecologic Oncology (35)
  2. Journal of Clinical Oncology (24)
  3. Journal for ImmunoTherapy of Cancer (20)
  4. Cancer Research (13)
  5. Clinical Cancer Research (11)
  6. International Journal of Gynecological Cancer (9)

More Publications

Publishers
  1. Elsevier Inc. (37)
  2. American Association for Cancer Research (32)
  3. American Society of Clinical Oncology (29)
  4. Biomed Central Ltd (20)
  5. Nature Publishing Group (20)
  6. Lippincott Williams & Wilkins (11)

More Publishers

Results (201)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gastrointestinal malignancies
    Book Section

    Lee, J. K.; Abou-Alfa, G.; Harding, J. J.; O'Reilly, E. M.; Reidy-Lagunes, D.; Eng, J.; Ilson, D. H.; Janjigian, Y. Y.; Saltz, L.; Zamarin, D.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Cancer immunology
    Book Section

    Hobbs, G.; Lesokhin, A. M.; Zamarin, D.; Wolchok, J. D.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy
    Journal Article

    Zamarin, D.; Holmgaard, R. B.; Subudhi, S. K.; Park, J. S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
    Meeting Abstract

    Zamarin, D.; Holmgaard, R.; Subudhi, S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: Incidence and prognostic significance
    Journal Article

    Zamarin, D.; Devlin, S. M.; Arcila, M. E.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Chimento, D.; Weltz, J.; Babu, D.; more...
    Leukemia (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase and T-cell based anti-tumor immunotherapies targeting immune checkpoints
    Meeting Abstract

    Holmgaard, R.; Zamarin, D.; Munn, D.; Wolchok, J.; Allison, J.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
    Journal Article

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal of Experimental Medicine (2013)

    Fulltext@MSK | Save
  • Patterns of relapse and progression in multiple myeloma patients after auto-SCT: Implications for patients' monitoring after transplantation
    Journal Article

    Zamarin, D.; Giralt, S.; Landau, H.; Lendvai, N.; Lesokhin, A.; Chung, D.; Koehne, G.; Chimento, D.; Devlin, S. M.; Riedel, E.; more...
    Bone Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Reactive polyclonal gammopathy associated with polyclonal plasmacytosis is common in patients with multiple myeloma receiving prolonged lenalidomide therapy: A retrospective study of 104 patients
    Meeting Abstract

    Zamarin, D.; Devlin, S.; Arcila, M.; Giralt, S. A.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Chimento, D.; Babu, D.; more...
    Blood (2012)

    Fulltext@MSK | Save